Compare · BOBS vs POM
BOBS vs POM
Side-by-side comparison of Bob's Discount Furniture Inc. (BOBS) and POMDOCTOR LIMITED (POM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BOBS and POM operate in Other Specialty Stores (Consumer Discretionary), so they compete in similar markets.
- BOBS is the larger of the two at $2.78B, about 48.3x POM ($57.5M).
- POM has been more active in the news (9 items in the past 4 weeks vs 6 for BOBS).
- BOBS has more recent analyst coverage (11 ratings vs 0 for POM).
- Company
- Bob's Discount Furniture Inc.
- POMDOCTOR LIMITED
- Price
- -
- -
- Market cap
- $2.78B
- $57.5M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Other Specialty Stores
- Other Specialty Stores
- Exchange
- NYSE
- NASDAQ
- IPO
- 2026
- 2025
- News (4w)
- 6
- 9
- Recent ratings
- 11
- 0
Latest BOBS
- Bob’s Discount Furniture Earns Dual Newsweek Honors for Customer Service and Online Shopping Experience
- SEC Form 10-Q filed by Bob's Discount Furniture Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Bob's Discount Furniture Inc.
- Bob's Discount Furniture Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Bob’s Discount Furniture Announces Third Quarter 2026 Financial Results
- Bob’s Discount Furniture Announces Third Quarter 2026 Conference Call Date
- Bob’s Discount Furniture Turns Social Content Into Sales with Season 2 of Hit Social Series “Till Decor Do Us Part”
- Bob's Discount Furniture Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 10-Q filed by Bob's Discount Furniture Inc.
- SEC Form SCHEDULE 13G filed by Bob's Discount Furniture Inc.
Latest POM
- POMDOCTOR LIMITED Highlights Real-World Data as a Strategic Foundation for AI-Enabled Healthcare Solutions
- SEC Form 6-K filed by POMDOCTOR LIMITED
- POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement
- SEC Form 6-K filed by POMDOCTOR LIMITED
- POMDOCTOR LIMITED Advances Strategic Evolution from Traffic Monetization to Value-Based Healthcare Payment
- SEC Form 6-K filed by POMDOCTOR LIMITED
- POMDOCTOR LIMITED Announces Receipt of Nasdaq Notifications Regarding Continued Listing Requirements
- POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq
- SEC Form 6-K filed by POMDOCTOR LIMITED
- POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare